Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-21-003974
Filing Date
2021-08-30
Accepted
2021-08-30 06:30:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 OTHER PROXY INFORMATION sonoma_defa.htm DEFA14A 6370
2 GRAPHIC image_002.jpg GRAPHIC 3824
3 GRAPHIC image_003.jpg GRAPHIC 3378
  Complete submission text file 0001683168-21-003974.txt   17632
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-33216 | Film No.: 211220822
SIC: 2834 Pharmaceutical Preparations